Cargando…
Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs)
BACKGROUND: The discovery of induced pluripotent stem cells (iPSCs) opened the possibilities for reprogramming cells back to a pluripotent state. Because of no apparent ethical issues connected with donation and derivation of biomaterial, iPSCs are considered as a research alternative to ethically h...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083011/ https://www.ncbi.nlm.nih.gov/pubmed/32192531 http://dx.doi.org/10.1186/s13287-020-01644-4 |
_version_ | 1783508456497479680 |
---|---|
author | Orzechowski, Marcin Schochow, Maximilian Kühl, Michael Steger, Florian |
author_facet | Orzechowski, Marcin Schochow, Maximilian Kühl, Michael Steger, Florian |
author_sort | Orzechowski, Marcin |
collection | PubMed |
description | BACKGROUND: The discovery of induced pluripotent stem cells (iPSCs) opened the possibilities for reprogramming cells back to a pluripotent state. Because of no apparent ethical issues connected with donation and derivation of biomaterial, iPSCs are considered as a research alternative to ethically highly disputed human embryonic stem cells (hESCs). However, the unique character of iPSCs leads to numerous ethical considerations, which mainly concern the issue of donor information and consent for the use of biospecimen in research and drug evaluation. METHODS: For the purpose of this analysis, we conducted a review of the literature in the PubMed/MEDLINE and Web of Science databases. The search algorithm led to the identification of 1461 results. After removing duplicates and screening of title and abstract, 90 articles were found to be relevant to the study’s objective. Full texts of these articles were apprised and 62 articles were excluded at this step for not properly addressing the study’s objective. In the final step, 28 articles were included in the analysis. Analyzed were both research and non-research manuscripts published in peer-reviewed journals. RESULTS: In the case of iPSC research, the information process should be guided by general frameworks established for research on human subjects but also by specific characteristics of iPSCs. We determined four main domains and 12 thematic subdomains that should be included in donor information. Our results show that majority of authors agree to the content of information with regard to the areas of general information, storage of cells, and protection of privacy. Two main issues that are discussed in the literature are donor’s consent for use in future studies and the process of donor information. CONCLUSIONS: Given the unique character of iPSCs and the possibility of their various uses in the future, the content of donor information should contain specific information central to iPSC research. Effective methods of communicating information to donors should combine written and oral information with the possible use of multimedia. |
format | Online Article Text |
id | pubmed-7083011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-70830112020-03-23 Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs) Orzechowski, Marcin Schochow, Maximilian Kühl, Michael Steger, Florian Stem Cell Res Ther Research BACKGROUND: The discovery of induced pluripotent stem cells (iPSCs) opened the possibilities for reprogramming cells back to a pluripotent state. Because of no apparent ethical issues connected with donation and derivation of biomaterial, iPSCs are considered as a research alternative to ethically highly disputed human embryonic stem cells (hESCs). However, the unique character of iPSCs leads to numerous ethical considerations, which mainly concern the issue of donor information and consent for the use of biospecimen in research and drug evaluation. METHODS: For the purpose of this analysis, we conducted a review of the literature in the PubMed/MEDLINE and Web of Science databases. The search algorithm led to the identification of 1461 results. After removing duplicates and screening of title and abstract, 90 articles were found to be relevant to the study’s objective. Full texts of these articles were apprised and 62 articles were excluded at this step for not properly addressing the study’s objective. In the final step, 28 articles were included in the analysis. Analyzed were both research and non-research manuscripts published in peer-reviewed journals. RESULTS: In the case of iPSC research, the information process should be guided by general frameworks established for research on human subjects but also by specific characteristics of iPSCs. We determined four main domains and 12 thematic subdomains that should be included in donor information. Our results show that majority of authors agree to the content of information with regard to the areas of general information, storage of cells, and protection of privacy. Two main issues that are discussed in the literature are donor’s consent for use in future studies and the process of donor information. CONCLUSIONS: Given the unique character of iPSCs and the possibility of their various uses in the future, the content of donor information should contain specific information central to iPSC research. Effective methods of communicating information to donors should combine written and oral information with the possible use of multimedia. BioMed Central 2020-03-19 /pmc/articles/PMC7083011/ /pubmed/32192531 http://dx.doi.org/10.1186/s13287-020-01644-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Orzechowski, Marcin Schochow, Maximilian Kühl, Michael Steger, Florian Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs) |
title | Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs) |
title_full | Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs) |
title_fullStr | Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs) |
title_full_unstemmed | Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs) |
title_short | Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs) |
title_sort | donor information in research and drug evaluation with induced pluripotent stem cells (ipscs) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083011/ https://www.ncbi.nlm.nih.gov/pubmed/32192531 http://dx.doi.org/10.1186/s13287-020-01644-4 |
work_keys_str_mv | AT orzechowskimarcin donorinformationinresearchanddrugevaluationwithinducedpluripotentstemcellsipscs AT schochowmaximilian donorinformationinresearchanddrugevaluationwithinducedpluripotentstemcellsipscs AT kuhlmichael donorinformationinresearchanddrugevaluationwithinducedpluripotentstemcellsipscs AT stegerflorian donorinformationinresearchanddrugevaluationwithinducedpluripotentstemcellsipscs |